MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CADL — Candel Therapeutics, Inc. Common Stock
NasdaqCandel Therapeutics, Inc. Common Stock
$10.18
+0.02(+0.20%)
- O
- 10.29
- H
- 10.37
- L
- 10.03
- V
- 877.87K
⏱️ End-of-day dataAs of Oct 2, 2026
CADL — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | 194,834.00 | 119,731.00 | 86,963.00 | 100,687.00 | 92,165.00 | 102,654.00 |
| Other Current Assets | 2,918.00 | 1,658.00 | 3,171.00 | 2,921.00 | 983.00 | 1,150.00 |
| Total Current Assets | 197,752.00 | 121,389.00 | 90,134.00 | 103,608.00 | 93,148.00 | 103,804.00 |
| Properties | 3,951.00 | 3,467.00 | 3,189.00 | 2,208.00 | 2,384.00 | 2,456.00 |
| Machinery Furniture Equipment | 387.00 | 386.00 | 347.00 | 290.00 | 260.00 | 244.00 |
| Leases | 3,008.00 | 3,008.00 | 3,004.00 | 3,109.00 | 3,109.00 | 3,109.00 |
| Accumulated Depreciation | -3,702.00 | -3,558.00 | -3,427.00 | -3,558.00 | -3,320.00 | -3,076.00 |
| Other Non Current Assets | 524.00 | 503.00 | 351.00 | 311.00 | 324.00 | 329.00 |
| Total Non Current Assets | 4,168.00 | 3,806.00 | 3,464.00 | 2,360.00 | 2,757.00 | 3,062.00 |
| Total Assets | 201,920.00 | 125,195.00 | 93,598.00 | 105,968.00 | 95,905.00 | 106,866.00 |
| Accounts Payable | 3,036.00 | 1,129.00 | 1,118.00 | 1,953.00 | 760.00 | 237.00 |
| Accrued Expenses | 3,473.00 | 7,334.00 | 5,149.00 | 4,318.00 | 2,720.00 | 5,113.00 |
| Short Term Debt | 453.00 | 445.00 | 4,662.00 | 7,298.00 | 9,752.00 | 10,461.00 |
| Other Current Liabilities | 89.00 | 89.00 | N/A | 1,146.00 | 6,837.00 | 21,718.00 |
| Total Current Liabilities | 7,051.00 | 8,997.00 | 10,929.00 | 14,715.00 | 20,069.00 | 37,529.00 |
| Long Term Debt | 48,818.00 | 48,589.00 | 2,545.00 | 1,043.00 | 1,161.00 | 3,010.00 |
| Derivative Product Liabilities | 7,955.00 | 15,598.00 | N/A | N/A | N/A | 0.00 |
| Total Non Current Liabilities | 56,840.00 | 64,276.00 | 2,545.00 | 1,043.00 | 1,161.00 | 3,010.00 |
| Total Liabilities | 63,891.00 | 73,273.00 | 13,474.00 | 15,758.00 | 21,230.00 | 40,539.00 |
| Common Stock | 733.00 | 550.00 | 550.00 | 549.00 | 493.00 | 469.00 |
| Retained Earnings | -239,248.00 | -230,387.00 | -200,891.00 | -189,622.00 | -184,826.00 | -192,205.00 |
| Total Shareholders Equity | 138,029.00 | 51,922.00 | 80,124.00 | 90,210.00 | 74,675.00 | 66,327.00 |
| Additional Paid In Capital | 376,992.00 | 282,207.00 | 280,913.00 | 279,731.00 | 259,456.00 | 258,511.00 |
| Treasury Stock | 448.00 | 448.00 | 448.00 | 448.00 | 448.00 | 448.00 |